Trial shows venetoclax/rituximab helps leukaemia patients- Roche
September 18, 2017 at 11:55 AM EDT
ZURICH, Sept 18 (Reuters) - Swiss drugmaker Roche said on Monday that a late-stage trial showed combining venetoclax plus rituximab treatments helped people with previously treated chronic lymphocytic leukaemia live longer without their disease worsening.
